Carel W le Roux Selected Research

Albuminuria

11/2022	Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial.
2/2022	Urinary Metabolomic Changes Accompanying Albuminuria Remission following Gastric Bypass Surgery for Type 2 Diabetic Kidney Disease.
1/2021	Bariatric surgery in the treatment of patients with obesity and type 1 diabetes: A retrospective study of clinical data.
1/2021	Impact of Metabolic Surgery on Renal Injury in Pre-Clinical Models of Diabetic Kidney Disease.
1/2020	Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?
1/2020	Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery.
1/2020	Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney disease.
12/2019	The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes.
10/2016	Mechanisms underpinning remission of albuminuria following bariatric surgery.
11/2014	Bariatric surgery and microvascular complications of type 2 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carel W le Roux Research Topics

Disease

114	Weight Loss (Weight Reduction) 03/2024 - 01/2006
109	Obesity 05/2024 - 01/2006
67	Type 2 Diabetes Mellitus (MODY) 02/2024 - 12/2010
36	Body Weight (Weight, Body) 02/2024 - 01/2006
18	Morbid Obesity 12/2022 - 09/2009
15	Diabetic Nephropathies (Diabetic Nephropathy) 12/2023 - 09/2014
14	Insulin Resistance 10/2022 - 12/2010
11	Neoplasms (Cancer) 11/2023 - 01/2011
11	Inflammation (Inflammations) 01/2022 - 05/2010
10	Albuminuria 11/2022 - 11/2014
9	Chronic Renal Insufficiency 02/2024 - 01/2018
7	Nausea 01/2023 - 08/2006
7	Overweight 12/2022 - 10/2012
6	Kidney Diseases (Kidney Disease) 12/2022 - 11/2013
6	Hypertension (High Blood Pressure) 12/2020 - 09/2009
5	Diabetes Mellitus 05/2022 - 02/2013
4	Prediabetic State (Prediabetes) 12/2022 - 01/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2011
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2024 - 01/2021
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2024 - 01/2016
3	Non-alcoholic Fatty Liver Disease 01/2023 - 10/2018
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 01/2020
3	Diabetes Complications 01/2021 - 09/2014
3	Hypertrophy 07/2010 - 09/2007
2	Hyperphagia (Overeating) 10/2023 - 10/2012
2	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 09/2012
2	Fibrosis (Cirrhosis) 01/2023 - 01/2021
2	Alcoholic Fatty Liver 01/2023 - 01/2022
2	Vomiting 01/2023 - 01/2021
2	Endometrial Neoplasms (Endometrial Cancer) 11/2022 - 01/2022
2	Chronic Disease (Chronic Diseases) 01/2022 - 01/2018
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 01/2019
2	Proteinuria 12/2020 - 07/2013
2	Necrosis 01/2020 - 01/2018
2	Infections 11/2019 - 03/2014
2	Cachexia 06/2019 - 12/2016
2	Dumping Syndrome (Syndrome, Dumping) 07/2017 - 06/2014
2	Glucose Intolerance 01/2017 - 09/2012
2	Diarrhea 07/2015 - 11/2009
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2015 - 02/2013
2	Metabolic Diseases (Metabolic Disease) 03/2013 - 02/2013

Drug/Important Bio-Agent (IBA)

31	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 07/2012
30	Hormones (Hormone)IBA 11/2022 - 01/2006
22	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2024 - 09/2007
18	Insulin (Novolin)FDA Link 12/2023 - 12/2010
13	Liraglutide FDA Link 05/2024 - 02/2015
13	Peptides (Polypeptides)IBA 02/2024 - 05/2008
12	semaglutideIBA 05/2024 - 11/2019
11	salicylhydroxamic acid (SHAM)IBA 12/2020 - 05/2010
10	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 11/2009
9	Glucagon-Like Peptide-1 ReceptorIBA 02/2024 - 01/2018
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2011
8	Peptide YYIBA 03/2016 - 08/2006
7	tirzepatideIBA 05/2024 - 11/2022
6	Glucagon (Glukagon)FDA Link 02/2024 - 09/2012
6	LipidsIBA 11/2022 - 02/2013
6	GhrelinIBA 01/2021 - 08/2006
5	LeptinIBA 01/2022 - 03/2011
5	Blood Glucose (Blood Sugar)IBA 01/2021 - 02/2015
5	CreatinineIBA 01/2020 - 06/2017
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2024 - 01/2022
4	Sodium-Glucose Transport ProteinsIBA 02/2024 - 09/2023
4	CholesterolIBA 02/2024 - 09/2017
4	Fatty Acids (Saturated Fatty Acids)IBA 11/2022 - 05/2014
4	Triglycerides (Triacylglycerol)IBA 02/2022 - 04/2015
4	AlbuminsIBA 01/2020 - 06/2017
3	IncretinsIBA 01/2023 - 03/2014
3	HDL CholesterolIBA 01/2023 - 01/2021
3	C-Reactive ProteinIBA 01/2022 - 01/2018
3	GlicentinIBA 01/2021 - 01/2020
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 02/2015
3	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2020 - 05/2008
3	CytokinesIBA 01/2016 - 05/2012
2	Naltrexone (ReVia)FDA LinkGeneric 05/2024 - 07/2022
2	Bupropion (Wellbutrin)FDA LinkGeneric 05/2024 - 07/2022
2	SodiumIBA 02/2024 - 01/2023
2	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 11/2019
2	MelanocortinsIBA 10/2023 - 07/2012
2	MicronutrientsIBA 02/2021 - 01/2019
2	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2021 - 08/2009
2	Phenobarbital (Luminal)FDA Link 12/2020 - 01/2011
2	CanagliflozinIBA 01/2020 - 11/2019
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2017
2	Peptide Hormones (Polypeptide Hormones)IBA 01/2018 - 01/2015
2	CarbohydratesIBA 07/2017 - 07/2012
2	Calcium Gluconate (CBG)IBA 03/2010 - 11/2009
2	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2010 - 11/2009

Therapy/Procedure

115	Bariatric Surgery 12/2023 - 01/2006
66	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2023 - 11/2007
32	Therapeutics 11/2023 - 01/2009
16	Gastrectomy 02/2024 - 07/2013
15	Glycemic Control 02/2024 - 01/2006
10	Drug Therapy (Chemotherapy) 11/2023 - 05/2014
5	Biliopancreatic Diversion 01/2018 - 09/2007
4	Obesity Management 12/2022 - 01/2022
3	Injections 09/2023 - 03/2022
3	Esophagectomy 01/2021 - 01/2019
2	Length of Stay 01/2021 - 03/2014
2	Combined Modality Therapy 01/2019 - 09/2015
2	Operative Surgical Procedures 08/2017 - 07/2013